Clinical trials
Virus Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 16 |
| 2021 | 9 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
| Unknown status | 11 |
| Recruiting | 8 |
| Terminated | 4 |
| Withdrawn | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 4 |
| Anabio R&D | 3 |
| Hospices Civils de Lyon | 3 |
| Beyond Air Inc. | 2 |
| Institut Pasteur | 2 |
| LucasBio | 2 |
| Marinomed Biotech AG | 2 |
| University of California, San Francisco | 2 |
| University of Edinburgh | 2 |
| AVB Biotechnology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Virus Diseases | 90 |
| Respiratory Tract Infections | 19 |
| COVID-19 | 17 |
| Bacterial Infections | 8 |
| Infections | 7 |
| Influenza, Human | 6 |
| Coronavirus Infections | 5 |
| HIV Infections | 5 |
| RNA Virus Infections | 5 |
| Acquired Immunodeficiency Syndrome | 4 |
Trials
Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.